Clinical Trials Directory

Trials / Unknown

UnknownNCT05598190

A577-nm Pro -Yellow Laser In Treatment of Striae Rubra

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Stretch marks or striae are common skin condition occurring in both genders, but they are more prevalent among women. These are linear dermal scars that are accompanied by epidermal atrophy. They usually occur frequently in numerous physiological and pathological conditions, such as adolescent growth, pregnancy, obesity, Cushing disease, Marfan syndrome, and long-term systemic or topical steroid use. Decreased expression of collagen and fibronectin genes has also been associated with striae. The pro-yellow laser systems can be used in a wide range of indications such as facial erythema, facial telangiectasia, port wine stain nevus, rosacea, poikilo derma civatte, and Becker's nevus Some of these indications are clinical lesions in the vascular pattern; some are related to the factors that trigger vascularity, such as vascular endothelial growth factor (VEGF) in etiopathogenesis

Conditions

Interventions

TypeNameDescription
DEVICEPro-Yellow laser 5774 session for cases with digtal photo before and after sessions

Timeline

Start date
2022-09-15
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2022-10-28
Last updated
2022-10-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05598190. Inclusion in this directory is not an endorsement.

A577-nm Pro -Yellow Laser In Treatment of Striae Rubra (NCT05598190) · Clinical Trials Directory